Bioconjugate Chemistry · 2008 · 72 citations · 27 references
PharmacyBiomedical EngineeringMedicinal ChemistryBiomedical ImagingBiophysical ChemistryMolecular ImagingAntibody ConjugatesAntibody ConjugationAntibody-drug ConjugatesContrast AgentsFluorescence ImagingTargeted Imaging AgentsAntibodiesAntibody - Fluorophore ConjugatesAntibody-based Imaging AgentsAntibody-fluorophore ConjugatesFluorescence Contrast AgentsMagnetic Resonance Imaging Contrast AgentsNanoparticle Imaging AgentsTargeted Molecular Imaging Agents
Water-soluble gadofullerides exhibited high efficiency as magnetic resonance imaging (MRI) contrast agents. In this paper, we report the conjugation of the newly synthesized gadofulleride, Gd@C82O6(OH) 16(-)(NHCH2CH2COOH)8, with the antibody of green fluorescence protein (anti-GFP), as a model for "tumor targeted" imaging agents based on endohedral metallofullerenes. In this model system, the activity of the anti-GFP conjugate can be conveniently detected by green fluorescence protein (GFP), leading to in vitro experiments more direct and facile than those of tumor antibodies. Objective-type total internal reflection fluorescence microscopy revealed that each gadofulleride aggregate conjugated on average five anti-GFPs, and the activity of anti-GFPs was preserved after conjugation. In addition, the gadofulleride/antibody conjugate exhibited higher water proton relaxivity (12.0 mM (-1) s (-1)) than the parent gadofulleride aggregate (8.1 mM (-1) s (-1)) in phosphate buffered saline at 0.35 T, as also confirmed by T1-weighted images of phantoms. These observations clearly indicate that the synthesized gadofulleride/antibody conjugate not only has targeting potential, but also exhibits higher efficiency as an MRI contrast agent.
27
Robert D. Bolskar, Angelo F. Benedetto, Lars O. Husebo et al. · Journal of the American Chemical Society · 2003 · 400 citations
Makio Tokunaga, K. Kitamura, Kiwamu Saito et al. · Biochemical and Biophysical Research Communications · 1997 · 309 citations